INVZ trades 771.3% below Wall Street's consensus target of $6.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes INVZ achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Innoviz Technologies Ltd. (INVZ) has a Wall Street consensus price target of $6.00, based on estimates from 5 covering analysts. With the stock currently trading at $0.69, this represents a potential upside of +771.3%. The company has a market capitalization of $152M.
Analyst price targets range from a low of $2.00 to a high of $13.00, representing a 183% spread in expectations. The median target of $3.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, INVZ trades at a trailing P/E of -2.0x. Analysts expect EPS to grow +17.9% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
LAZRLuminar Technologies, Inc. | $24.3B | $40.74 | $86.00 | +111.1% | Buy | — | 9 |
OUSTOuster, Inc. | $2.8B | $44.06 | $56.00 | +27.1% | Hold | — | 9 |
AEVAAeva Technologies, Inc. | $1.4B | $21.57 | $8.74 | -59.5% | Buy | — | 8 |
LIDRAEye, Inc. | $62M | $1.34 | $12.00 | +795.5% | Hold | — | 4 |
MVISMicroVision, Inc. | $125M | $0.38 | $5.00 | +1223.1% | Buy | — | 8 |
MBLYMobileye Global Inc. | $7.7B | $9.50 | $13.32 | +40.2% | Buy | 34.3x | 26 |
APTVAptiv PLC | $12.5B | $58.85 | $88.63 | +50.6% | Buy | 9.5x | 33 |
INDIindie Semiconductor, Inc. | $871M | $4.12 | $4.75 | +15.3% | Buy | — | 7 |
CEVACEVA, Inc. | $1.2B | $42.76 | $45.40 | +6.2% | Buy | 80.9x | 25 |
TSLATesla, Inc. | $1.5T | $402.90 | $443.70 | +10.1% | Hold | 212.8x | 81 |
Quick answers to the most common questions about buying INVZ stock.
The consensus Wall Street price target for INVZ is $6, representing 771.3% upside from the current price of $0.6886. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
INVZ has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $6 implies 771.3% upside from current levels.
INVZ's current price is $0.6886 with a consensus target of $6 (771.3% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $13 for INVZ, while the most conservative target is $2. The consensus of $6 represents the median expectation. These targets typically reflect 12-month expectations.
INVZ is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month INVZ stock forecast based on 5 Wall Street analysts shows a consensus price target of $6, with estimates ranging from $2 (bear case) to $13 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on INVZ, with a "Buy" consensus rating and $6 price target (771.3% upside). 3 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
INVZ analyst price targets range from $2 to $13, a 183% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $6 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.